Nephroprotective effect of ACE inhibitors

Area of Science:

• Nephrology
• Pharmacology

Background:

• Renal disease progression often involves nonspecific mechanisms like glomerulosclerosis and tubulointerstitial fibrosis.
• Systemic hypertension exacerbates renal damage by affecting glomerular microcirculation.
• Glomerular growth is implicated in the development of glomerulosclerosis.

Purpose of the Study:

• To investigate the renoprotective effects of angiotensin converting enzyme (ACE) inhibitors.
• To explore mechanisms of ACE inhibitor action beyond their hemodynamic effects.

Main Methods:

• Review of experimental and clinical studies on ACE inhibitors in renal disease.
• Analysis of prospective clinical trials assessing proteinuria and disease progression.

Main Results:

• ACE inhibitors show potential in preventing progressive renal deterioration.
• Evidence suggests renoprotective effects are partly dissociated from blood pressure lowering.
• ACE inhibitors reduce proteinuria and slow disease progression more than expected from blood pressure effects alone.

Conclusions:

• ACE inhibitors offer renal protection through mechanisms potentially involving glomerular growth and permselectivity.
• Further research is investigating the roles of reduced angiotensin II generation and kinin accumulation.
• Clinical trials confirm ACE inhibitors' significant impact on slowing renal disease progression.